On May 1, Organovo Holdings Inc (NYSEMKT:ONVO) spiked 9.16% after the company announced that it has initiated contracting for toxicity testing using its 3D Human Liver Tissue for selected clients prior to full release. Organovo Holdings Inc (NYSEMKT:ONVO) weekly performance is 8.96%. On last trading day company shares ended up $7.30. Organovo Holdings Inc (NYSEMKT:ONVO) distance from 50-day simple moving average (SMA50) is 2.84%.
Shares of Seadrill Ltd (NASDAQ:SDRL) saw unusually large options trading on Tuesday. Traders purchased 4,315 put options on the stock,American Banking News reports. This represents an increase of 182% compared to the typical daily volume of 1,528 put options.Seadrill Ltd (NYSE:SDRL) shares advanced 3.27% in last trading session and ended the day on $37.56. Gross Margin is 57.70% and its return on assets is 11.30%. Seadrill Ltd (NYSE:SDRL) quarterly performance is 9.28%.
On May 26, North Atlantic Drilling Ltd. (NYSE:NADL) and Seadrill Limited are pleased to announce that an Investment and Co-operation Agreement (“the Agreement”) has been executed with Rosneft in order to pursue growth opportunities offshore and onshore in the Russian market through at least 2022. As part of these proposed opportunities, NADL will enter the onshore drilling market in Russia and enter into contracts for multiple offshore assets. In addition Rosneft will be acquiring a significant equity stake in NADL. North Atlantic Drilling Ltd. (NYSE:NADL) shares moved up 13.53% in last trading session and was closed at $9.65, while trading in range of $8.92 – $9.70.
Novogen Limited (ADR) (NASDAQ:NVGN), an oncology drug development company, announced that it has achieved a key milestone with its super-benzopyran (SBP) drug program, having identified a number of SBP compounds with potent anti-cancer activity against human prostate cancer cells in vitro. As a result, Novogen has extended its preclinical SBP program to include prostate cancer as well as ovarian and brain cancers. Novogen Limited (ADR) (NASDAQ:NVGN) ended the last trading day at $3.88. Company weekly volatility is calculated as 7.95% and price to cash ratio as 9.60. Novogen Limited (ADR) (NASDAQ:NVGN) showed a positive weekly performance of 4.30%.
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) has received a consensus recommendation of “Buy” from the eight analysts that are covering the stock, American Banking News reports. Two analysts have rated the stock with a sell rating and six have given a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $11.57. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) net profit margin is -57.10% and weekly performance is 3.26%. On last trading day company shares ended up $7.92. Analysts mean target price for the company is $10.92. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) distance from 50-day simple moving average (SMA50) is 7.57%.